Merck is spending $2.7 billion for ArQule, a small biotechnology company that is still in the earlier stages of studying potential treatments for conditions ...
News
- Stocks are mostly lower on Wall Street with trade in focus
- New Menarini CELLSEARCH Studies to be Presented at San Antonio Breast Cancer Symposium
New Menarini CELLSEARCH Studies to be Presented at San Antonio .... biotechnology and diagnostics company headquartered in Florence, Italy, ...
- Researchers identify top ways to stop projected 142% rise in Latino cancer
26-28, 2020, in San Antonio, is open for registration. ... nursing, dentistry, health professions and graduate biomedical sciences have produced 36,500 ...
- ArQule and Fate Therapeutics soar; Sanofi and Diplomat fall
The drug developer is buying biotechnology firm Synthorx, which focuses on potential cancer treatments, for $2.5 billion. ArQule Inc., up $10.04 to ...
- Lab worker caught a deadly rare virus – from a research monkey
Mr Lee, of San Antonio, , was struck down with it while working at Texas Biomedical Research Institute, where 2,500 primates are tested for research ...